Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tawil

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Seminars in Neurology|March 11, 2000
Outlook for therapy in the muscular dystrophiesR Tawil
The Cochrane Database of Systematic Reviews|April 24, 2004
Drug treatment for facioscapulohumeral muscular dystrophyM R Rose, R Tawil
Heliyon|July 21, 2021
New recommender system evaluation approaches based on user selections factorM Kshour, M Ebrahimi, S Goliaee, et al.
Neurology|June 1, 1993
Acetazolamide-induced nephrolithiasis: implications for treatment of neuromuscular disordersR Tawil, R T Moxley, R C Griggs
Annals of Neurology|March 20, 1998
Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH ConsortiumR Tawil, D A Figlewicz, R C Griggs, et al.
Archives of Neurology|November 1, 1995
Scapuloperoneal syndromes. Absence of linkage to the 4q35 FSHD locusR Tawil, G J Myers, B Weiffenbach, et al.
Neurology|February 1, 1992
Linkage of atypical myotonia congenita to a sodium channel locusL J Ptacek, R Tawil, R C Griggs, et al.
Neurology|February 1, 1993
Extreme variability of expression in monozygotic twins with FSH muscular dystrophyR Tawil, D Storvick, T E Feasby, et al.
Neurology|November 1, 1993
Genetics of facioscapulohumeral muscular dystrophy: new mutations in sporadic casesR C Griggs, R Tawil, D Storvick, et al.
Physical Therapy|March 1, 1994
Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY GroupK E Personius, S Pandya, W M King, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Seminars in Neurology|March 11, 2000
Outlook for therapy in the muscular dystrophiesR Tawil
The Cochrane Database of Systematic Reviews|April 24, 2004
Drug treatment for facioscapulohumeral muscular dystrophyM R Rose, R Tawil
Heliyon|July 21, 2021
New recommender system evaluation approaches based on user selections factorM Kshour, M Ebrahimi, S Goliaee, et al.
Neurology|June 1, 1993
Acetazolamide-induced nephrolithiasis: implications for treatment of neuromuscular disordersR Tawil, R T Moxley, R C Griggs
Annals of Neurology|March 20, 1998
Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH ConsortiumR Tawil, D A Figlewicz, R C Griggs, et al.
Archives of Neurology|November 1, 1995
Scapuloperoneal syndromes. Absence of linkage to the 4q35 FSHD locusR Tawil, G J Myers, B Weiffenbach, et al.
Neurology|February 1, 1992
Linkage of atypical myotonia congenita to a sodium channel locusL J Ptacek, R Tawil, R C Griggs, et al.
Neurology|February 1, 1993
Extreme variability of expression in monozygotic twins with FSH muscular dystrophyR Tawil, D Storvick, T E Feasby, et al.
Neurology|November 1, 1993
Genetics of facioscapulohumeral muscular dystrophy: new mutations in sporadic casesR C Griggs, R Tawil, D Storvick, et al.
Physical Therapy|March 1, 1994
Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY GroupK E Personius, S Pandya, W M King, et al.
Pageof 4